JP6637026B2 - 遺伝子改変された(r)−乳酸産生好熱性細菌 - Google Patents
遺伝子改変された(r)−乳酸産生好熱性細菌 Download PDFInfo
- Publication number
- JP6637026B2 JP6637026B2 JP2017502827A JP2017502827A JP6637026B2 JP 6637026 B2 JP6637026 B2 JP 6637026B2 JP 2017502827 A JP2017502827 A JP 2017502827A JP 2017502827 A JP2017502827 A JP 2017502827A JP 6637026 B2 JP6637026 B2 JP 6637026B2
- Authority
- JP
- Japan
- Prior art keywords
- gene
- lactic acid
- seq
- weight
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical class C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 title claims description 42
- 241000894006 Bacteria Species 0.000 title description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 70
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 66
- 241000193390 Parageobacillus thermoglucosidasius Species 0.000 claims description 65
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 63
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 57
- 229930182843 D-Lactic acid Natural products 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 39
- 238000004519 manufacturing process Methods 0.000 claims description 34
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 34
- 239000004310 lactic acid Substances 0.000 claims description 33
- 235000014655 lactic acid Nutrition 0.000 claims description 33
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 22
- 101150041530 ldha gene Proteins 0.000 claims description 22
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 230000001580 bacterial effect Effects 0.000 claims description 18
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 17
- 108010008221 formate C-acetyltransferase Proteins 0.000 claims description 17
- 235000019253 formic acid Nutrition 0.000 claims description 17
- 239000006227 byproduct Substances 0.000 claims description 16
- 241000626621 Geobacillus Species 0.000 claims description 14
- 238000012217 deletion Methods 0.000 claims description 14
- 230000037430 deletion Effects 0.000 claims description 14
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 13
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 13
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 13
- 230000002779 inactivation Effects 0.000 claims description 13
- 101150083023 mgsA gene Proteins 0.000 claims description 13
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- JVTAAEKCZFNVCJ-UWTATZPHSA-M (R)-lactate Chemical compound C[C@@H](O)C([O-])=O JVTAAEKCZFNVCJ-UWTATZPHSA-M 0.000 claims description 11
- 101710088194 Dehydrogenase Proteins 0.000 claims description 11
- 230000028070 sporulation Effects 0.000 claims description 11
- 241000894007 species Species 0.000 claims description 10
- 229930006000 Sucrose Natural products 0.000 claims description 9
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 9
- 230000006801 homologous recombination Effects 0.000 claims description 9
- 238000002744 homologous recombination Methods 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 8
- 101100139916 Escherichia coli (strain K12) rarA gene Proteins 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 230000002950 deficient Effects 0.000 claims description 7
- 101150067544 sigF gene Proteins 0.000 claims description 7
- JVTAAEKCZFNVCJ-REOHCLBHSA-M (S)-lactate Chemical compound C[C@H](O)C([O-])=O JVTAAEKCZFNVCJ-REOHCLBHSA-M 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 108010083856 methylglyoxal synthase Proteins 0.000 claims description 5
- 101150076489 B gene Proteins 0.000 claims description 4
- 108700023175 Phosphate acetyltransferases Proteins 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 7
- 210000004027 cell Anatomy 0.000 description 46
- 238000000855 fermentation Methods 0.000 description 37
- 230000004151 fermentation Effects 0.000 description 37
- 239000013612 plasmid Substances 0.000 description 33
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 30
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 28
- 229960005091 chloramphenicol Drugs 0.000 description 27
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 27
- 230000000694 effects Effects 0.000 description 25
- 238000011144 upstream manufacturing Methods 0.000 description 21
- 101100454398 Lactiplantibacillus plantarum (strain ATCC BAA-793 / NCIMB 8826 / WCFS1) ldh1 gene Proteins 0.000 description 20
- 101150104734 ldh gene Proteins 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 19
- 108020004414 DNA Proteins 0.000 description 18
- 239000002773 nucleotide Substances 0.000 description 18
- 125000003729 nucleotide group Chemical group 0.000 description 18
- 235000011054 acetic acid Nutrition 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 15
- 230000004048 modification Effects 0.000 description 15
- 238000012986 modification Methods 0.000 description 15
- 101150014383 adhE gene Proteins 0.000 description 14
- 239000012634 fragment Substances 0.000 description 14
- 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 description 13
- 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 description 13
- 101150026107 ldh1 gene Proteins 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 238000010276 construction Methods 0.000 description 12
- 108010001539 D-lactate dehydrogenase Proteins 0.000 description 11
- 238000004520 electroporation Methods 0.000 description 11
- 230000037361 pathway Effects 0.000 description 11
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 244000057717 Streptococcus lactis Species 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 230000010354 integration Effects 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 229940076788 pyruvate Drugs 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 6
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 6
- 238000001030 gas--liquid chromatography Methods 0.000 description 6
- 108020004705 Codon Proteins 0.000 description 5
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 5
- 101100083037 Streptococcus mutans serotype c (strain ATCC 700610 / UA159) act gene Proteins 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 101150049339 pflA gene Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 101100049641 Caenorhabditis elegans pfs-2 gene Proteins 0.000 description 3
- 238000007399 DNA isolation Methods 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 3
- 108010022065 Lactate racemase Proteins 0.000 description 3
- 108010011939 Pyruvate Decarboxylase Proteins 0.000 description 3
- 102100033598 Triosephosphate isomerase Human genes 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 108010060146 pyruvate formate-lyase activating enzyme Proteins 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WIIZWVCIJKGZOK-IUCAKERBSA-N 2,2-dichloro-n-[(1s,2s)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide Chemical compound ClC(Cl)C(=O)N[C@@H](CO)[C@@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-IUCAKERBSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PSJQCAMBOYBQEU-UHFFFAOYSA-N Glyoxalase I Natural products CC=CC(=O)OCC1=CC(O)C(O)C(O)C1=O PSJQCAMBOYBQEU-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 102000014017 Lactoylglutathione lyase Human genes 0.000 description 2
- 108010050765 Lactoylglutathione lyase Proteins 0.000 description 2
- 108090000856 Lyases Proteins 0.000 description 2
- 102000004317 Lyases Human genes 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 108010065064 acetaldehyde dehydrogenase (acylating) Proteins 0.000 description 2
- RHHGBCYEBPMXAF-BLPRJPCASA-N acetaldehyde;[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(3r)-3-hydroxy-2,2-dimethyl-4-oxo-4-[[3-oxo-3-(2-sulfanylethylamino)propyl]amino]butyl] hydrogen phosphate Chemical compound CC=O.O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RHHGBCYEBPMXAF-BLPRJPCASA-N 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- QWDJLDTYWNBUKE-UHFFFAOYSA-L magnesium bicarbonate Chemical compound [Mg+2].OC([O-])=O.OC([O-])=O QWDJLDTYWNBUKE-UHFFFAOYSA-L 0.000 description 2
- 239000002370 magnesium bicarbonate Substances 0.000 description 2
- 229910000022 magnesium bicarbonate Inorganic materials 0.000 description 2
- 235000014824 magnesium bicarbonate Nutrition 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- HNSDLXPSAYFUHK-UHFFFAOYSA-N 1,4-bis(2-ethylhexyl) sulfosuccinate Chemical compound CCCCC(CC)COC(=O)CC(S(O)(=O)=O)C(=O)OCC(CC)CCCC HNSDLXPSAYFUHK-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- 241000195597 Chlamydomonas reinhardtii Species 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000193419 Geobacillus kaustophilus Species 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 241001468175 Geobacillus thermodenitrificans Species 0.000 description 1
- 241001468176 Geobacillus thermoleovorans Species 0.000 description 1
- 241000652008 Geobacillus tropicalis Species 0.000 description 1
- 241000589232 Gluconobacter oxydans Species 0.000 description 1
- 241000522069 Gracilaria debilis Species 0.000 description 1
- 241000621271 Gymnomyces pallidus Species 0.000 description 1
- 101000861519 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Probable formate transporter Proteins 0.000 description 1
- 102100040544 Hydroxyacylglutathione hydrolase, mitochondrial Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241001621940 Parageobacillus caldoxylosilyticus Species 0.000 description 1
- 241001663853 Parageobacillus toebii Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- 241001464969 Sporolactobacillus laevolacticus Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 241000588902 Zymomonas mobilis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000009604 anaerobic growth Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000909 electrodialysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 101150077334 focA gene Proteins 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 108010092127 glyoxalase III Proteins 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- -1 hydrogen salt Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 108010025042 hydroxyacylglutathione hydrolase Proteins 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 101150004519 pilC gene Proteins 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229930010796 primary metabolite Natural products 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- FCHXJFJNDJXENQ-UHFFFAOYSA-N pyridoxal hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(C=O)=C1O FCHXJFJNDJXENQ-UHFFFAOYSA-N 0.000 description 1
- PFIPZKASKUWLHH-UHFFFAOYSA-N pyridoxamine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CN)=C1O PFIPZKASKUWLHH-UHFFFAOYSA-N 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000010282 redox signaling Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000012465 retentate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000014621 translational initiation Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01028—D-Lactate dehydrogenase (1.1.1.28)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01008—Phosphate acetyltransferase (2.3.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01054—Formate C-acetyltransferase (2.3.1.54), i.e. pyruvate formate-lyase or PFL
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03003—Methylglyoxal synthase (4.2.3.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01027—L-Lactate dehydrogenase (1.1.1.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07006—DNA-directed RNA polymerase (2.7.7.6)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
a)内在性(S)−乳酸デヒドロゲナーゼ遺伝子の不活化または欠損;
b)(R)−乳酸デヒドロゲナーゼ遺伝子の導入;
c)内在性ピルビン酸ギ酸リアーゼAおよび/またはB遺伝子の不活化または欠損
を含む細胞を開示する。
菌株およびプラスミド
本研究において用いられた菌株およびプラスミドが、表1に記載される。
標準的なDNA操作技術が、SambrookおよびRussell(Sambrook & Russell, 2001, Molecular Cloning, a laboratory manual. 3rd edition. Cold Spring Harbor Laboratory Press, New York)によって記載されているように実行された。
G. thermoglucosidansが、Crippsら(Crippsら、2009、Metab. Eng.11:398-408)によって記載されたプロトコルに基づいて、エレクトロポレーションによって形質転換された。G. thermoglucosidansは、55℃で一晩増殖され、そして1mLが、バッフルを備えた250ml三角フラスコ中の予め温められた50mlのTGP培地に接種するために用いられた。OD600が約1.0となるまで、細胞が60℃(180rpm)にてインキュベートされた。フラスコは10分間氷上で冷却され、そして細胞が遠心分離(4℃)によってペレット化された。次に、細胞が、氷冷されたエレクトロポレーションバッファー(0.5Mソルビトール、0.5Mマンニトール、10%(v/v)グリセリン)で4回洗浄された。洗浄工程の容量は、50ml、25ml、10mlおよび10mlであった。最終ペレットは、1.3mlの氷冷されたエレクトロポレーションバッファー中に再懸濁され、そしてエレクトロコンピテントセルの60μlのアリコートが−80℃にて貯蔵され、またはエレクトロポレーションに直接用いられた。
Geobacillus-E.coliシャトルベクターpNW33nが、先に記載されたように(Crippsら、2009、Metab. Eng.11:398-408)、G. thermoglucosidansにおける組込み型ベクターとして用いられた。8μg/mLのクロラムフェニコールを含有する20mLのTGPに、グリセリンストックからの形質転換された菌株が接種された。55℃、180rpmにて一晩の増殖後、適切な希釈物が、8μg/mLのクロラムフェニコールを含有するTGPプレート上にプレーティングされた。その後、これらのプレートは、68℃にて24時間インキュベートされた。シングルコロニーが、新鮮なプレート(52℃でインキュベートされた)に画線され、これらのコロニーにおいてコロニーPCRが行われて、シングルクロスオーバーを有するコロニーを同定した。適切なプライマー組合せが、上流断片または下流断片を介したシングルクロスオーバーを同定するのに用いられた(表2;それぞれ、pRM3の組込みのための655−170および656−571のプライマー組合せ、pRM12の組込みのための744−170および808−571のプライマー組合せ、pFS3の組込みのための629−170および630−571のプライマー組合せ、pJS43の組込みのための754−170および991−571のプライマー組合せ)。次に、陽性コロニーの染色体DNAが、Masterpure Gram Positive DNA Purification Kit(Epicentre Biotechnologies)を用いて単離され、そして、コロニーPCRの結果を確かめるために、上記PCRが、単離された染色体DNAに関して繰り返された。上流隣接領域を介したシングルクロスオーバーおよび下流隣接領域を介したシングルクロスオーバーが、第2の組換え工程のために選択された。
TMM培地は、Fongら(Fongら、2006)から改変され、そして1Lにつき、60g/Lのグルコース;30g/Lのキシロース;8.37gのMOPS、0.23gのK2HPO4;0.51gのNH4Cl;0.50gのNaCl;1.47gのNa2SO4;0.08gのNaHCO3;0.25gのKCl;1.87gのMgCl2・6H2O;0.41gのCaCl2・2H2O;16.0mgのMnCl2・4H2O;1.0mgのZnSO4・7H2O;2.0mgのH3BO3;0.1mgのCuSO4・5H2O;0.1mgのNa2MoO4・2H2O;1.0mgのCoCl2・6H2O;7.0mgのFeSO4・7H2O;0.1mgのチアミン;0.1mgのリボフラビン;0.5mgのニコチン酸;0.1mgのパントテン酸;0.5mgのピリドキサミンHCl;0.5mgのピリドキサールHCl;0.1mgのD−ビオチン;0.1mgの葉酸;0.1mgのp−アミノ安息香酸;0.1mgのコバラミンを含んでいた。pHはpH7.2に調整された。グルコース、キシロース、金属およびビタミンは、フィルター滅菌された。培地はオートクレーブ処理された。TMM1、TMM2.5およびTMM5はそれぞれ、1g/L、2.5g/Lおよび5g/Lの酵母抽出物(Oxoid)で補充されていた。
G. thermoglucosidansによるホモ乳酸型の乳酸産生
G. thermoglucosidans中のsigF遺伝子を欠損させるために、組込み型プラスミドpRM3が構築された。sigF遺伝子の上流および下流隣接領域は、鋳型としてのDSM 2542のゲノムDNA、ならびに上流断片を得るための653と654のプライマー組合せ(表2)および下流断片を得るための651と652のプライマー組合せ(表2)を用いたPCRによって生成された。最初に、下流断片が、KpnI−SalI断片として、同じ酵素で切断されたpNW33n中にクローニングされた。次に、上流断片が、SalI−HindIII断片として、同じ酵素で切断されたこの構築物中にクローニングされて、プラスミドpRM3を結果した。pRM3の構築は、E. coli TG90においてなされた。pRM3配列の完全性(integrity)は、DNA配列決定によって確かめられた。
hdhDを用いた(R)−乳酸産生G. thermoglucosidans誘導体の構築
L. delbrueckiiに由来し、かつD−乳酸デヒドロゲナーゼ活性をコードするhdhD遺伝子による、天然のldhL遺伝子の遺伝子置き換えを促進するためのプラスミドpFS3が構築された。構築物は、hdhD開始コドンおよび終止コドンが、元のldhL開始コドンおよび終止コドンの位置に取って代わり、そしてldhLプロモーターへのhdhDの翻訳融合を結果するものであった。ldhL遺伝子の下流隣接領域は、鋳型としてのDSM 2542のゲノムDNA、および624と631のプライマー組合せを用いたPCRによって生成された。産物は、SalIおよびSphIで切断され、そしてSalIおよびSphIで切断されたpNW33n中に連結された。得られたプラスミドは、pFS2と命名された。pFS2の構築は、E. coli DH5αにおいてなされた。
ldhAを用いた(R)−乳酸産生G. thermoglucosidans誘導体の構築
E. coliにおけるLactobacillus属の種に由来するldhA遺伝子のクローニングは、問題があることが知られている(Bernardら、1991、FEBS Lett.290:61-64)。起こりうるクローニング問題を回避するために、本発明者らは、中間宿主としてL. lactisを使用し、クローニングベクターとしてpNZ124を使用することに決めた。L. delbrueckiiに由来し、かつD−乳酸デヒドロゲナーゼ活性をコードするldhAによる、天然のldhL遺伝子の遺伝子置き換えを促進するために、プラスミドpJS65が構築された。構築は、ldhA開始コドンおよび終止コドンが、元のldhL開始コドンおよび終止コドンの位置に取って代わり、そしてldhAのldhLプロモーターへの翻訳融合をもたらすものであった。
G. thermoglucosidansによるエナンチオピュアのホモ型乳酸産生
G. thermoglucosidans中のmgsA遺伝子(423bp)の267bpを欠損させるためにプラスミドpJS43が構築された。mgsA遺伝子の上流および下流隣接領域は、鋳型としてのDSM 2542のゲノムDNA、ならびに、mgsA下流断片を得るための750と999のプライマー組合せおよび上流mgsA断片を獲得するための1000と753のプライマー組合せを用いたPCRによって生成された。得られた2つのPCR産物は次いで、これらを一緒に融合するために、750と753のプライマー組合せを用いたオーバーラップPCRにおいて鋳型として用いられた。産物は、BamHI−PstI断片として、BamHIおよびPstIで切断されたプラスミドpNW33n中にクローニングされて、プラスミドpJS43を結果した。pJS43の構築は、E. coli TG90においてなされた。pJS43ヌクレオチド配列の完全性は、配列決定によって確かめられた。
Claims (16)
- 通性嫌気性であり、Geobacillus属に属する、遺伝子操作された好熱細菌細胞であって、下記:
a)内在性の(S)−乳酸デヒドロゲナーゼ遺伝子の不活化または欠損;
b)(R)−乳酸デヒドロゲナーゼ遺伝子の導入、ここで、該(R)−乳酸デヒドロゲナーゼ遺伝子は、配列番号38のアミノ酸配列若しくは配列番号38のアミノ酸配列に対して少なくとも90%の同一性を有するアミノ酸配列をコードする、Lactobacillus delbrueckii由来のhdhD遺伝子、又は配列番号36のアミノ酸配列若しくは配列番号36のアミノ酸配列に対して少なくとも90%の同一性を有するアミノ酸配列をコードする、Lactobacillus delbrueckii由来のldhA遺伝子から選択される;
c)内在性のピルビン酸ギ酸リアーゼAおよび/またはB遺伝子の及びアルコールデヒドロゲナーゼ遺伝子の不活化または欠損
を含む細胞。 - さらに、内在性のメチルグリオキサールシンターゼ遺伝子mgsAが不活化されまたは欠損している、請求項1に記載の細胞。
- 前記hdhD遺伝子が、配列番号38のアミノ酸配列をコードする、請求項1に記載の細胞。
- 前記ldhA遺伝子が、配列番号36のアミノ酸配列をコードする、請求項1に記載の細胞。
- さらに、内在性のホスホトランスアセチラーゼ遺伝子(pta)が不活化されまたは欠損している、請求項1〜4のいずれか1項に記載の細胞。
- 内在性の胞子形成遺伝子の不活化または欠損故の胞子形成欠損誘導体である、請求項1〜5のいずれか1項に記載の細胞。
- 前記胞子形成遺伝子がsigFである、請求項6に記載の細胞。
- 前記ピルビン酸ギ酸リアーゼAおよび/またはB遺伝子が、内在性のピルビン酸ギ酸リアーゼ/アルコールデヒドロゲナーゼ遺伝子座pflBA−adhEの不活化または欠損によって不活化されている、請求項1〜7のいずれか1項に記載の細胞。
- 少なくとも98%、より好ましくは少なくとも99%、99.5%、99.8%または99.9%のエナンチオマー純度を有する(R)−乳酸を産生する、請求項1〜8のいずれか1項に記載の細胞。
- 前記遺伝子が、相同組換えによって改変されている、請求項1〜9のいずれか1項に記載の細菌細胞。
- 前記Geobacillus属の種がGeobacillus thermoglucosidansである、請求項1〜10のいずれか1項に記載の細胞。
- エナンチオマー的に純粋な(R)−乳酸の産生方法であって、適切な発酵性炭素含有供給原料を用いて、請求項1〜11のいずれか1項に記載の好熱細菌細胞を培養すること、そして(R)−乳酸を単離することを含む方法。
- 前記炭素含有供給原料が、キシロース、グルコースまたはスクロースを含む、請求項12に記載の方法。
- 前記培養が、50℃〜70℃の温度で行われる、請求項12または13に記載の方法。
- 産生された乳酸の総重量に対する副産物の総重量に基づいて、15重量%以下、特に10重量%以下、または5重量%、4重量%、3重量%もしくは2重量%以下の副産物が形成される、請求項12〜14のいずれか1項に記載の方法。
- ギ酸、エタノールおよび酢酸の少なくとも1つの形成量が、産生された乳酸の総重量に対するギ酸、エタノールまたは酢酸の総重量に基づいて、5重量%以下、特に2重量%、1重量%、0.25重量%または0.1重量%以下である、請求項12〜15のいずれか1項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14178144.3 | 2014-07-23 | ||
EP14178144 | 2014-07-23 | ||
PCT/EP2015/065990 WO2016012296A1 (en) | 2014-07-23 | 2015-07-13 | Genetically modified (r)-lactic acid producing thermophilic bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017523778A JP2017523778A (ja) | 2017-08-24 |
JP6637026B2 true JP6637026B2 (ja) | 2020-01-29 |
Family
ID=51211697
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017502827A Active JP6637026B2 (ja) | 2014-07-23 | 2015-07-13 | 遺伝子改変された(r)−乳酸産生好熱性細菌 |
Country Status (12)
Country | Link |
---|---|
US (1) | US10731186B2 (ja) |
EP (1) | EP3194592B1 (ja) |
JP (1) | JP6637026B2 (ja) |
KR (1) | KR101980069B1 (ja) |
CN (1) | CN106574236B (ja) |
AU (1) | AU2015294136C9 (ja) |
BR (1) | BR112017000846B1 (ja) |
CA (1) | CA2955717C (ja) |
ES (1) | ES2821418T3 (ja) |
PL (1) | PL3194592T3 (ja) |
PT (1) | PT3194592T (ja) |
WO (1) | WO2016012296A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018109101A1 (en) | 2016-12-14 | 2018-06-21 | Wageningen Universiteit | Thermostable cas9 nucleases |
CA3119086A1 (en) | 2018-11-30 | 2020-06-04 | Utilization Of Carbon Dioxide Institute Co., Ltd. | Lactic acid-producing hydrogenophilus bacterium transformant |
JP6675574B1 (ja) | 2019-08-09 | 2020-04-01 | 株式会社Co2資源化研究所 | 乳酸を生成する遺伝子組換えヒドロゲノフィラス属細菌 |
CN111154705B (zh) * | 2020-01-07 | 2021-06-29 | 中国科学院微生物研究所 | 热葡萄糖苷酶地芽孢杆菌工程菌及其构建方法及应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4336082B2 (ja) | 2001-05-29 | 2009-09-30 | 花王株式会社 | 宿主微生物 |
GB0117551D0 (en) * | 2001-07-18 | 2001-09-12 | Elsworth Biotech Ltd | Lastic acid production |
US9497168B2 (en) | 2002-07-30 | 2016-11-15 | Avaya Inc. | Method and apparatus for supporting communications between a computing device within a network and an external computing device |
CN1809631B (zh) | 2003-06-18 | 2010-05-26 | 帝斯曼知识产权资产管理有限公司 | 用不能形成芽孢的微生物来生产泛酸盐/酯的方法 |
US7098009B2 (en) * | 2004-03-04 | 2006-08-29 | University Of Florida Research Foundation, Inc. | Production of chemicals from lignocellulose, biomass or sugars |
PL2305826T3 (pl) * | 2005-08-10 | 2016-10-31 | Materiały i sposoby do wydajnej produkcji kwasu mlekowego | |
WO2007120198A2 (en) | 2005-11-08 | 2007-10-25 | University Of Florida Research Foundation, Inc. | Materials and methods for improved microbial production of organic compounds |
EP1989309B1 (en) * | 2006-01-24 | 2011-08-31 | PURAC Biochem BV | Genetic modification of homolactic thermophilic bacilli |
CA2818680A1 (en) * | 2010-11-22 | 2012-05-31 | Qingzhao Wang | Engineering of thermotolerant bacillus coagulans for production of d(-)-lactic acid |
KR101438882B1 (ko) | 2012-04-24 | 2014-09-05 | 씨제이제일제당 (주) | 신규한 d형 젖산 생산균주 |
JPWO2014017469A1 (ja) * | 2012-07-23 | 2016-07-11 | 三井化学株式会社 | D−乳酸の生産方法およびポリマーの生産方法 |
-
2015
- 2015-07-13 US US15/327,495 patent/US10731186B2/en active Active
- 2015-07-13 PL PL15741963T patent/PL3194592T3/pl unknown
- 2015-07-13 CA CA2955717A patent/CA2955717C/en active Active
- 2015-07-13 AU AU2015294136A patent/AU2015294136C9/en active Active
- 2015-07-13 BR BR112017000846-7A patent/BR112017000846B1/pt active IP Right Grant
- 2015-07-13 WO PCT/EP2015/065990 patent/WO2016012296A1/en active Application Filing
- 2015-07-13 PT PT157419631T patent/PT3194592T/pt unknown
- 2015-07-13 ES ES15741963T patent/ES2821418T3/es active Active
- 2015-07-13 CN CN201580040167.3A patent/CN106574236B/zh active Active
- 2015-07-13 JP JP2017502827A patent/JP6637026B2/ja active Active
- 2015-07-13 KR KR1020177001921A patent/KR101980069B1/ko active IP Right Grant
- 2015-07-13 EP EP15741963.1A patent/EP3194592B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2955717A1 (en) | 2016-01-28 |
JP2017523778A (ja) | 2017-08-24 |
EP3194592A1 (en) | 2017-07-26 |
EP3194592B1 (en) | 2020-07-08 |
AU2015294136C1 (en) | 2018-10-25 |
KR101980069B1 (ko) | 2019-05-20 |
BR112017000846A2 (pt) | 2018-07-31 |
PL3194592T3 (pl) | 2021-02-08 |
AU2015294136C9 (en) | 2019-05-02 |
AU2015294136A1 (en) | 2017-02-09 |
BR112017000846B1 (pt) | 2024-01-16 |
WO2016012296A1 (en) | 2016-01-28 |
US10731186B2 (en) | 2020-08-04 |
US20170275656A1 (en) | 2017-09-28 |
CA2955717C (en) | 2020-09-22 |
AU2015294136B2 (en) | 2018-04-26 |
CN106574236B (zh) | 2020-12-11 |
CN106574236A (zh) | 2017-04-19 |
KR20170019467A (ko) | 2017-02-21 |
ES2821418T3 (es) | 2021-04-26 |
PT3194592T (pt) | 2020-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013215706B2 (en) | Recombinant microorganisms and methods of use thereof | |
JP6637026B2 (ja) | 遺伝子改変された(r)−乳酸産生好熱性細菌 | |
JP2016529901A (ja) | アラニンの生産向上のための改変微生物 | |
JP6580051B2 (ja) | コハク酸生産のための改善された微生物 | |
JP2010017131A (ja) | モーレラ属細菌及びプライマー | |
JP2019088328A (ja) | (s)−乳酸産生好熱性細菌の遺伝子改変 | |
JP7158107B2 (ja) | 有機化合物の生産方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170315 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180606 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180905 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181030 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20181129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20181130 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190508 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20190731 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190924 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191203 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20191219 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6637026 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |